Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	ZNF717 ZNF536 HIVEP1 ZNF658 HDX ZNF485 ZNF226 SKIL ZNF658B RFX3 STAT5A ZNF490 ZIK1 ZNF780A MTOR ZNF665 PRMT5 ZNF347 GMEB1 ZNF808 ZNF701	8.70e-07	1271	99	21	GO:0000987
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	ZNF717 ZNF536 HIVEP1 ZNF658 HDX ZNF485 ZNF226 SKIL ZNF658B RFX3 ZNF440 STAT5A ZNF518A ZNF490 ZIK1 ZNF780A ZNF665 ZNF347 GMEB1 ZNF808 ELF2 ZNF701	1.21e-06	1412	99	22	GO:0000981
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	ZNF717 ZNF536 HIVEP1 ZNF658 HDX ZNF485 ZNF226 SKIL ZNF658B RFX3 ZNF440 STAT5A ZNF518A ZNF490 ZIK1 ZNF780A ZNF665 PRMT5 ZNF347 GMEB1 ZNF808 ZNF701	2.08e-06	1459	99	22	GO:0000977
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	ZNF717 ZNF536 HIVEP1 ZNF658 HDX ZNF485 ZNF226 SKIL ZNF658B RFX3 STAT5A ZNF490 ZIK1 ZNF780A ZNF665 PRMT5 ZNF347 GMEB1 ZNF808 ZNF701	2.53e-06	1244	99	20	GO:0000978
Domain	ZINC_FINGER_C2H2_2	ZNF536 ZNF609 HIVEP1 ZNF658 ZNF485 ZNF226 ZNF440 ZNF518A ZNF490 PRDM10 ZIK1 ZNF780A ZNF665 ARID2 ZNF347 ZNF808 ZNF701	1.09e-06	775	103	17	PS50157
Domain	ZINC_FINGER_C2H2_1	ZNF536 ZNF609 HIVEP1 ZNF658 ZNF485 ZNF226 ZNF440 ZNF518A ZNF490 PRDM10 ZIK1 ZNF780A ZNF665 ARID2 ZNF347 ZNF808 ZNF701	1.13e-06	777	103	17	PS00028
Domain	Znf_C2H2-like	ZNF536 ZNF609 HIVEP1 ZNF658 ZNF485 ZNF226 ZNF440 ZNF518A ZNF490 PRDM10 ZIK1 ZNF780A ZNF665 ARID2 ZNF347 ZNF808 ZNF701	1.57e-06	796	103	17	IPR015880
Domain	Znf_C2H2	ZNF536 ZNF609 HIVEP1 ZNF658 ZNF485 ZNF226 ZNF440 ZNF518A ZNF490 PRDM10 ZIK1 ZNF780A ZNF665 ARID2 ZNF347 ZNF808 ZNF701	1.83e-06	805	103	17	IPR007087
Domain	ZnF_C2H2	ZNF536 ZNF609 HIVEP1 ZNF658 ZNF485 ZNF226 ZNF440 ZNF518A ZNF490 PRDM10 ZIK1 ZNF780A ZNF665 ARID2 ZNF347 ZNF808 ZNF701	1.92e-06	808	103	17	SM00355
Domain	zf-C2H2	ZNF536 HIVEP1 ZNF658 ZNF485 ZNF226 ZNF440 ZNF518A ZNF490 PRDM10 ZIK1 ZNF780A ZNF665 ZNF347 ZNF808 ZNF701	5.89e-06	693	103	15	PF00096
Domain	Znf_C2H2/integrase_DNA-bd	ZNF536 HIVEP1 ZNF658 ZNF485 ZNF226 ZNF440 ZNF518A ZNF490 PRDM10 ZIK1 ZNF780A ZNF665 ZNF347 ZNF808 ZNF701	6.00e-06	694	103	15	IPR013087
Domain	-	ZNF536 HIVEP1 ZNF658 ZNF485 ZNF226 ZNF440 ZNF490 PRDM10 ZIK1 ZNF780A ZNF665 ZNF347 ZNF808 ZNF701	2.13e-05	679	103	14	3.30.160.60
Domain	KRAB	ZNF658 ZNF485 ZNF226 ZNF440 ZNF490 ZIK1 ZNF780A ZNF347 ZNF808 ZNF701	2.87e-05	358	103	10	PS50805
Domain	KRAB	ZNF658 ZNF485 ZNF226 ZNF440 ZNF490 ZIK1 ZNF780A ZNF347 ZNF808 ZNF701	2.87e-05	358	103	10	PF01352
Domain	KRAB	ZNF658 ZNF485 ZNF226 ZNF440 ZNF490 ZIK1 ZNF780A ZNF347 ZNF808 ZNF701	3.71e-05	369	103	10	SM00349
Domain	KRAB	ZNF658 ZNF485 ZNF226 ZNF440 ZNF490 ZIK1 ZNF780A ZNF347 ZNF808 ZNF701	3.79e-05	370	103	10	IPR001909
Domain	FATC	MTOR ATM	2.98e-04	5	103	2	PF02260
Domain	HOOK	CCDC88C CCDC88A	4.45e-04	6	103	2	PF05622
Domain	FAT	MTOR ATM	4.45e-04	6	103	2	PS51189
Domain	FATC	MTOR ATM	4.45e-04	6	103	2	PS51190
Domain	FAT	MTOR ATM	4.45e-04	6	103	2	PF02259
Domain	Hook-related_fam	CCDC88C CCDC88A	4.45e-04	6	103	2	IPR008636
Domain	PIK-rel_kinase_FAT	MTOR ATM	4.45e-04	6	103	2	IPR003151
Domain	FATC_dom	MTOR ATM	4.45e-04	6	103	2	IPR003152
Domain	PIK_FAT	MTOR ATM	4.45e-04	6	103	2	IPR014009
Domain	FATC	MTOR ATM	4.45e-04	6	103	2	SM01343
Domain	EGF_LAM_2	LAMB4 CELSR2 USH2A	5.93e-04	30	103	3	PS50027
Domain	EGF_LAM_1	LAMB4 CELSR2 USH2A	5.93e-04	30	103	3	PS01248
Domain	EGF_Lam	LAMB4 CELSR2 USH2A	9.38e-04	35	103	3	SM00180
Domain	Laminin_EGF	LAMB4 CELSR2 USH2A	9.38e-04	35	103	3	PF00053
Domain	RFX_DNA_binding	RFX3 ARID2	1.06e-03	9	103	2	PF02257
Domain	DNA-bd_RFX	RFX3 ARID2	1.06e-03	9	103	2	IPR003150
Domain	RFX_DBD	RFX3 ARID2	1.06e-03	9	103	2	PS51526
Domain	Laminin_EGF	LAMB4 CELSR2 USH2A	1.19e-03	38	103	3	IPR002049
Domain	BAH	ASH1L TNRC18	1.60e-03	11	103	2	PS51038
Domain	BAH_dom	ASH1L TNRC18	1.60e-03	11	103	2	IPR001025
Domain	BAH	ASH1L TNRC18	1.60e-03	11	103	2	SM00439
Domain	BAH	ASH1L TNRC18	1.60e-03	11	103	2	PF01426
Domain	zf-C2H2_6	ZNF658 ZNF440 ZNF490 PRDM10 ZNF780A ZNF808 ZNF701	1.78e-03	314	103	7	PF13912
Domain	-	SKIL GMEB1	1.92e-03	12	103	2	3.10.390.10
Domain	SAND_dom-like	SKIL GMEB1	1.92e-03	12	103	2	IPR010919
Domain	ARM-type_fold	APOB WDFY4 NF1 MTOR ARID2 ATM GCN1	2.73e-03	339	103	7	IPR016024
Domain	PI3/4_kinase_CS	MTOR ATM	3.02e-03	15	103	2	IPR018936
Domain	-	MTOR ATM	3.44e-03	16	103	2	1.10.1070.11
Domain	Laminin_N	LAMB4 USH2A	3.44e-03	16	103	2	IPR008211
Domain	PI3Kc	MTOR ATM	3.44e-03	16	103	2	SM00146
Domain	LamNT	LAMB4 USH2A	3.44e-03	16	103	2	SM00136
Domain	LAMININ_NTER	LAMB4 USH2A	3.44e-03	16	103	2	PS51117
Domain	Laminin_N	LAMB4 USH2A	3.44e-03	16	103	2	PF00055
Domain	LH2	PKD1L1 LPL	4.35e-03	18	103	2	SM00308
Domain	PI3_PI4_kinase	MTOR ATM	4.35e-03	18	103	2	PF00454
Domain	PI3_4_KINASE_1	MTOR ATM	4.35e-03	18	103	2	PS00915
Domain	PI3_4_KINASE_2	MTOR ATM	4.35e-03	18	103	2	PS00916
Domain	PI3/4_kinase_cat_dom	MTOR ATM	4.35e-03	18	103	2	IPR000403
Domain	PI3_4_KINASE_3	MTOR ATM	4.35e-03	18	103	2	PS50290
Pathway	REACTOME_GENERIC_TRANSCRIPTION_PATHWAY	BRIP1 HIPK2 ZNF226 SKIL ZNF490 ZIK1 ZNF780A MTOR ZNF665 PRMT5 ZNF347 ZNF808 ELF2 ATM	8.24e-05	768	79	14	MM14851
Pathway	WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2	APOB GHR LPL	9.00e-05	16	79	3	M42564
Pathway	WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS	SKIL NF1 PRMT5	1.30e-04	18	79	3	M39825
Pubmed	Human transcription factor protein interaction networks.	ASXL1 ZNF536 TRAF3 ZNF609 HIVEP1 RTCB ZNF485 HIPK2 CEP192 STAT5A STAU1 ARID2 XRN1 GMEB1 AGK ELF2 CTTN PCCA	3.12e-07	1429	106	18	35140242
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	EFCAB5 FLNB CENPC ZNF658 BAG1 ASH1L APOB ANKLE2 TNRC18 N4BP2 XRN1 ANKRD30A KRT20 CEP295 ATM ITIH6 CTTN ATP5F1A	3.56e-07	1442	106	18	35575683
Pubmed	Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.	ATXN2L FLNB RTCB HDX STAU1 CCDC88C CCDC88A N4BP2 PRMT5 CTTN ATP5F1A	1.02e-06	551	106	11	34728620
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	ATXN2L FLNB ARHGEF12 SPART ANKLE2 STAU1 CCDC88A XRN1 AGK CTTN GCN1 ATP5F1A	1.78e-06	708	106	12	39231216
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	ATXN2L MCMBP HIVEP1 RTCB CEP192 CCDC88C PTPN3 CCDC88A NF1 MTOR N4BP2 PRMT5 XRN1	2.29e-06	861	106	13	36931259
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	FLNB ZNF536 ZNF609 HIVEP1 CCDC88A N4BP2 XRN1 PCCA GCN1	5.64e-06	418	106	9	34709266
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	ATXN2L ZNF609 BRIP1 HIVEP1 CENPC RTCB STAU1 ARID2 ZNF808 ELF2 CTTN PCCA ATP5F1A	6.95e-06	954	106	13	36373674
Pubmed	Growth hormone receptor contributes to the activation of STAT5 in the hypothalamus of pregnant mice.	STAT5A GHR	9.20e-06	2	106	2	34929316
Pubmed	Role of candidate genes in the lipid responses to intensified treatment in Type 2 diabetes.	APOB LPL	9.20e-06	2	106	2	16419488
Pubmed	TRAF3 can interact with GMEB1 and modulate its anti-apoptotic function.	TRAF3 GMEB1	9.20e-06	2	106	2	32514408
Pubmed	Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.	STAT5A MTOR	9.20e-06	2	106	2	25468562
Pubmed	Chromatin regulator Asxl1 loss and Nf1 haploinsufficiency cooperate to accelerate myeloid malignancy.	ASXL1 NF1	9.20e-06	2	106	2	30226831
Pubmed	Apolipoprotein B production reduces lipotoxic cardiomyopathy: studies in heart-specific lipoprotein lipase transgenic mouse.	APOB LPL	9.20e-06	2	106	2	14634011
Pubmed	Excessive STAU1 condensate drives mTOR translation and autophagy dysfunction in neurodegeneration.	STAU1 MTOR	9.20e-06	2	106	2	38913026
Pubmed	Quantitative acetylome and phosphorylome analysis reveals Girdin affects pancreatic cancer progression through regulating Cortactin.	CCDC88A CTTN	9.20e-06	2	106	2	32369440
Pubmed	Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5.	STAT5A GHR	9.20e-06	2	106	2	11067862
Pubmed	Loss of growth hormone-mediated signal transducer and activator of transcription 5 (STAT5) signaling in mice results in insulin sensitivity with obesity.	STAT5A GHR	9.20e-06	2	106	2	30779881
Pubmed	NF-κB/mTOR/MYC Axis Drives PRMT5 Protein Induction After T Cell Activation via Transcriptional and Non-transcriptional Mechanisms.	MTOR PRMT5	9.20e-06	2	106	2	30941147
Pubmed	Cortactin controls surface expression of the voltage-gated potassium channel K(V)10.1.	KCNH1 CTTN	9.20e-06	2	106	2	23144454
Pubmed	NF1 patient missense variants predict a role for ATM in modifying neurofibroma initiation.	NF1 ATM	9.20e-06	2	106	2	31664505
Pubmed	[Relationship of gallstone formation after radical gastrectomy with the polymorphisms of apolipoprotein B Xba I and lipoprotein lipase Hind III gene].	APOB LPL	9.20e-06	2	106	2	20099167
Pubmed	Downregulation of BAG‑1 in T47D cells promotes resistance to tamoxifen via activation of the PI3K/Akt/mTOR signaling pathway.	BAG1 MTOR	9.20e-06	2	106	2	30747221
Pubmed	Hyperactivation of mTOR critically regulates abnormal osteoclastogenesis in neurofibromatosis Type 1.	NF1 MTOR	9.20e-06	2	106	2	21748792
Pubmed	Insulin inhibition of apolipoprotein B mRNA translation is mediated via the PI-3 kinase/mTOR signaling cascade but does not involve internal ribosomal entry site (IRES) initiation.	APOB MTOR	9.20e-06	2	106	2	17698027
Pubmed	Revealing the clinical impact of MTOR and ARID2 gene mutations on MALT lymphoma of the alimentary canal using targeted sequencing.	MTOR ARID2	9.20e-06	2	106	2	39054516
Pubmed	Enhanced apoB48 metabolism in lipoprotein lipase X447 homozygotes.	APOB LPL	9.20e-06	2	106	2	16989840
Pubmed	Cep295 is a conserved scaffold protein required for generation of a bona fide mother centriole.	CEP192 CEP295	9.20e-06	2	106	2	27562453
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	SLC39A9 PKD1L1 CEP192 ANKLE2 CCDC88C CCDC88A N4BP2 PRMT5 XRN1 CEP295 CTTN PCCA	1.17e-05	853	106	12	28718761
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	ATXN2L MCMBP HIVEP1 TBC1D2B HIPK2 SPART CEP192 CCDC88A N4BP2 ARID2	1.32e-05	588	106	10	38580884
Pubmed	Functional proteomics mapping of a human signaling pathway.	FLNB HIVEP1 ASH1L SPART SKIL ANKLE2 ZNF518A STAU1 EPG5 GMEB1	1.38e-05	591	106	10	15231748
Pubmed	Association of sixty-one non-synonymous polymorphisms in forty-one hypertension candidate genes with blood pressure variation and hypertension.	APOB GHR LPL	1.50e-05	16	106	3	17137217
Pubmed	The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression.	ASXL1 PRDM10 ELF2	1.50e-05	16	106	3	20805357
Pubmed	Joint effects of common genetic variants from multiple genes and pathways on the risk of premature coronary artery disease.	APOB CELSR2 LPL	1.50e-05	16	106	3	20691829
Pubmed	A human MAP kinase interactome.	HIVEP1 HIPK2 ZNF440 PTPN3 CCDC88A N4BP2 ARID2 KRT20 GCN1	1.87e-05	486	106	9	20936779
Pubmed	Acetylation-Mimic Mutation of TRIM28-Lys304 to Gln Attenuates the Interaction with KRAB-Zinc-Finger Proteins and Affects Gene Expression in Leukemic K562 Cells.	ZNF485 ZNF440 ZNF490 ZNF780A ZNF701 GCN1	2.03e-05	181	106	6	37372979
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	TBC1D2B CEP192 ANKLE2 SBSN STAU1 XRN1	2.22e-05	184	106	6	32908313
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	TOPAZ1 TBC1D2B PTPN22 BEND4 STAT5A ARID2 ATM CTTN COPS6	2.23e-05	497	106	9	36774506
Pubmed	Analysis of HIV-1 Gag protein interactions via biotin ligase tagging.	ATXN2L FLNB XRN1 CTTN	2.29e-05	54	106	4	25631074
Pubmed	The Effect of the NFκB-USP9X-Cx43 Axis on the Dynamic Balance of Bone Formation/Degradation during Ossification of the Posterior Longitudinal Ligament of the Cervical Spine.	APOB CCDC88A PRMT5 ATP5F1A	2.29e-05	54	106	4	35391932
Pubmed	C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme.	APOB NF1	2.76e-05	3	106	2	11727199
Pubmed	The JAK-STAT transcriptional regulator, STAT-5, activates the ATM DNA damage pathway to induce HPV 31 genome amplification upon epithelial differentiation.	STAT5A ATM	2.76e-05	3	106	2	23593005
Pubmed	The autoimmunity-associated gene PTPN22 potentiates toll-like receptor-driven, type 1 interferon-dependent immunity.	TRAF3 PTPN22	2.76e-05	3	106	2	23871208
Pubmed	Aryl hydrocarbon receptor-mediated suppression of GH receptor and Janus kinase 2 expression in mice.	STAT5A GHR	2.76e-05	3	106	2	14759523
Pubmed	Regulation of mTOR activity in Snell dwarf and GH receptor gene-disrupted mice.	GHR MTOR	2.76e-05	3	106	2	25456069
Pubmed	F-actin rearrangement is regulated by mTORC2/Akt/Girdin in mouse fertilized eggs.	CCDC88A MTOR	2.76e-05	3	106	2	27666957
Pubmed	Growth hormone promotes the association of transcription factor STAT5 with the growth hormone receptor.	STAT5A GHR	2.76e-05	3	106	2	8702683
Pubmed	Altered metabolism of growth hormone receptor mutant mice: a combined NMR metabonomics and microarray study.	STAT5A GHR	2.76e-05	3	106	2	18648510
Pubmed	ATM-Mediated Phosphorylation of Cortactin Involved in Actin Polymerization Promotes Breast Cancer Cells Migration and Invasion.	ATM CTTN	2.76e-05	3	106	2	30562756
Pubmed	Genetic association study of selected candidate genes (ApoB, LPL, Leptin) and telomere length in obese and hypertensive individuals.	APOB LPL	2.76e-05	3	106	2	19772655
Pubmed	ATM protein physically and functionally interacts with proliferating cell nuclear antigen to regulate DNA synthesis.	MTOR ATM	2.76e-05	3	106	2	22362778
Pubmed	Coronary artery disease and dyslipidemia within Europe: genetic variants in lipid transport gene loci in German subjects with premature coronary artery disease.	APOB LPL	2.76e-05	3	106	2	12044583
Pubmed	Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis.	HIPK2 ATM	2.76e-05	3	106	2	11780126
Pubmed	Growth hormone/STAT5 signaling in proopiomelanocortin neurons regulates glucoprivic hyperphagia.	STAT5A GHR	2.76e-05	3	106	2	31494175
Pubmed	Stat5 is critical for the development and maintenance of myeloproliferative neoplasm initiated by Nf1 deficiency.	STAT5A NF1	2.76e-05	3	106	2	27418650
Pubmed	mTOR direct crosstalk with STAT5 promotes de novo lipid synthesis and induces hepatocellular carcinoma.	STAT5A MTOR	2.76e-05	3	106	2	31409773
Pubmed	Aberrant CD8+ T-cell responses and memory differentiation upon viral infection of an ataxia-telangiectasia mouse model driven by hyper-activated Akt and mTORC1 signaling.	MTOR ATM	2.76e-05	3	106	2	21641396
Pubmed	ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS.	MTOR ATM	2.76e-05	3	106	2	20160076
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	FLNB MCMBP HIVEP1 RTCB APOB STAU1 NF1 MTOR PRMT5 NEMF AGK ATM CTTN GCN1 ATP5F1A	2.80e-05	1425	106	15	30948266
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	APOB CCDC88C CCDC88A ZNF665 LPL XRN1 LRRC37B ATP5F1A ALPK2	2.85e-05	513	106	9	25798074
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	ATXN2L FLNB RTCB STAU1 NF1 MTOR PRMT5 XRN1 ATM GCN1	3.21e-05	653	106	10	22586326
Pubmed	SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.	ATXN2L ZNF609 RTCB STAU1 TNRC18 PRMT5 AGK CTTN GCN1 ATP5F1A	3.30e-05	655	106	10	35819319
Pubmed	Genetic variants in LPL, OASL and TOMM40/APOE-C1-C2-C4 genes are associated with multiple cardiovascular-related traits.	APOB CELSR2 LPL	3.52e-05	21	106	3	21943158
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ZNF536 ZNF609 ASH1L SKIL TEP1 WDR37 ZNF518A HMCN2 ARID2 XRN1 CRNN CEP295 PCCA	3.59e-05	1116	106	13	31753913
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	ZNF609 HIVEP1 ASH1L SKIL RFX3 STAT5A ZNF665 ARID2 ZNF347 GMEB1 ELF2	3.73e-05	808	106	11	20412781
Pubmed	Regulation of ETAA1-mediated ATR activation couples DNA replication fidelity and genome stability.	EFCAB5 ZNF536 ZNF609 SLC25A34 CCDC88A	3.73e-05	122	106	5	31615875
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	FLNB TRAF3 MCMBP RTCB PPEF1 SBSN PTPN3 MTOR EIF2B3 XRN1 CTTN GCN1	4.28e-05	974	106	12	28675297
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	ATXN2L FLNB ANKLE2 STAU1 TNRC18 CCDC88A NF1 CELSR2 XRN1 CTTN PCCA GCN1 NOS1	4.43e-05	1139	106	13	36417873
Pubmed	The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1.	ATXN2L MCMBP ARID2 NEMF XRN1 AGK	4.91e-05	212	106	6	33853758
Pubmed	MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.	NF1 MTOR	5.50e-05	4	106	2	24509877
Pubmed	Wnt-1 signal induces phosphorylation and degradation of c-Myb protein via TAK1, HIPK2, and NLK.	HIPK2 NLK	5.50e-05	4	106	2	15082531
Pubmed	The Trithorax protein Ash1L promotes myoblast fusion by activating Cdon expression.	ASH1L CDON	5.50e-05	4	106	2	30487570
Pubmed	Heterozygous mutation of ataxia-telangiectasia mutated gene aggravates hypercholesterolemia in apoE-deficient mice.	APOB ATM	5.50e-05	4	106	2	15863839
Pubmed	p53 and NF 1 loss plays distinct but complementary roles in glioma initiation and progression.	NF1 MTOR	5.50e-05	4	106	2	29392777
Pubmed	Integrated case-control and somatic-germline interaction analyses of soft-tissue sarcoma.	BAG1 NF1	5.50e-05	4	106	2	32447321
Pubmed	mTORC1 signaling under hypoxic conditions is controlled by ATM-dependent phosphorylation of HIF-1α.	MTOR ATM	5.50e-05	4	106	2	21095582
Pubmed	Are the so-called low penetrance breast cancer genes, ATM, BRIP1, PALB2 and CHEK2, high risk for women with strong family histories?	BRIP1 ATM	5.50e-05	4	106	2	18557994
Pubmed	Lipid-related genes and myocardial infarction in 4685 cases and 3460 controls: discrepancies between genotype, blood lipid concentrations, and coronary disease risk.	APOB LPL	5.50e-05	4	106	2	15256516
Pubmed	Bortezomib inhibits STAT5-dependent degradation of LEF-1, inducing granulocytic differentiation in congenital neutropenia CD34(+) cells.	STAT5A NLK	5.50e-05	4	106	2	24394665
Pubmed	Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects.	STAT5A GHR	5.50e-05	4	106	2	11133161
Pubmed	ATM mediates phosphorylation at multiple p53 sites, including Ser(46), in response to ionizing radiation.	HIPK2 ATM	5.50e-05	4	106	2	11875057
Pubmed	Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions.	NF1 MTOR ARID2 ATM	6.77e-05	71	106	4	28319113
Pubmed	Genome-wide association analysis of metabolic traits in a birth cohort from a founder population.	APOB CELSR2 LPL	6.80e-05	26	106	3	19060910
Pubmed	5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia.	NF1 MTOR ATM	7.63e-05	27	106	3	23027611
Pubmed	Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR.	HIPK2 ATM	9.15e-05	5	106	2	18536714
Pubmed	The lipoprotein lipase serine 447 stop polymorphism is associated with altered serum carotenoid concentrations in the Stanislas Family Study.	APOB LPL	9.15e-05	5	106	2	18187430
Pubmed	[Genetic Predictors of Unfavorable Course in High Risk Patients With Ischemic Heart Disease. Data of Follow-up for Two Years.].	APOB LPL	9.15e-05	5	106	2	15699916
Pubmed	LDL-cholesterol concentrations: a genome-wide association study.	APOB CELSR2	9.15e-05	5	106	2	18262040
Pubmed	mTOR masters monocyte development in bone marrow by decreasing the inhibition of STAT5 on IRF8.	STAT5A MTOR	9.15e-05	5	106	2	29463562
Pubmed	Growth hormone enhances the recovery of hypoglycemia via ventromedial hypothalamic neurons.	STAT5A GHR	9.15e-05	5	106	2	31366244
Pubmed	Neutral sphingomyelinase 2 deficiency increases hyaluronan synthesis by up-regulation of Hyaluronan synthase 2 through decreased ceramide production and activation of Akt.	MTOR HAS2	9.15e-05	5	106	2	22383528
Pubmed	The adaptor protein TRAF3 inhibits interleukin-6 receptor signaling in B cells to limit plasma cell development.	TRAF3 PTPN22	9.15e-05	5	106	2	26329582
Pubmed	Mammalian protein-protein interaction trap (MAPPIT) analysis of STAT5, CIS, and SOCS2 interactions with the growth hormone receptor.	STAT5A GHR	9.15e-05	5	106	2	17666591
Pubmed	Lipid profiles and associated gene polymorphisms in young Asian Indian patients with acute myocardial infarction and the metabolic syndrome.	APOB LPL	9.15e-05	5	106	2	19642912
Pubmed	Analysis of lipid pathway genes indicates association of sequence variation near SREBF1/TOM1L2/ATPAF2 with dementia risk.	APOB CELSR2 LPL	9.49e-05	29	106	3	20167577
Pubmed	Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis.	APOB CELSR2 LPL	1.05e-04	30	106	3	19936222
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	FLNB ASH1L HIPK2 UNC13D APOB CEP192 ANKLE2 WDFY4 ZNF780A KCNH1 CEP295 ATP5F1A	1.18e-04	1084	106	12	11544199
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	HIVEP1 PKD1L1 ARHGEF12 PTPN22 GHR NF1 HMCN2	1.24e-04	361	106	7	26167880
Pubmed	Nsp2 has the potential to be a drug target revealed by global identification of SARS-CoV-2 Nsp2-interacting proteins.	MCMBP GMEB1 AGK GCN1	1.30e-04	84	106	4	34159380
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ATXN2L RTCB SPART STAU1 ARID2 XRN1 ELF2 CTTN PCCA GCN1 ATP5F1A	1.35e-04	934	106	11	33916271
Pubmed	The Wnt-NLK signaling pathway inhibits A-Myb activity by inhibiting the association with coactivator CBP and methylating histone H3.	HIPK2 NLK	1.37e-04	6	106	2	16055500
Cytoband	17q11.2	EFCAB5 STAT5A NF1 NLK	1.28e-04	110	106	4	17q11.2
Cytoband	Ensembl 112 genes in cytogenetic band chr17q11	EFCAB5 NF1 LRRC37B NLK	6.87e-04	171	106	4	chr17q11
Cytoband	Ensembl 112 genes in cytogenetic band chr19q13	ZNF226 SBSN ZIK1 KCNC3 ZNF780A ZNF665 ZNF347 ZNF808 ZNF701	1.80e-03	1192	106	9	chr19q13
Cytoband	9p12	BAG1 ZNF658B	2.06e-03	29	106	2	9p12
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF717 ZNF536 ZNF609 HIVEP1 ZNF658 ZNF485 ZNF226 ZNF440 ZNF518A ZNF490 PRDM10 ZIK1 ZNF780A ZNF665 ZNF347 ZNF808 ZNF701	1.75e-09	718	71	17	28
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	ATXN2L MDFIC CLSTN3 ZNF609 MCMBP CENPC ASH1L TBC1D2B UNC13D PTPN22 ANKLE2 STAT5A EPG5 CCDC88C CCDC88A ARID2 NEMF XRN1 ATM	6.74e-06	1492	105	19	M40023
Coexpression	HALLMARK_MITOTIC_SPINDLE	FLNB ARHGEF12 CEP192 STAU1 CCDC88A NF1 CTTN	1.59e-05	199	105	7	M5893
Disease	Hypertriglyceridemia	APOB CELSR2 LPL	1.67e-05	15	100	3	C0020557
Disease	Hyperlipoproteinemia Type IIa	APOB GHR LPL	2.05e-05	16	100	3	C0745103
Disease	very low density lipoprotein cholesterol measurement, esterified cholesterol measurement	APOB CELSR2 LPL	2.97e-05	18	100	3	EFO_0008317, EFO_0008589
Disease	cholesteryl esters to total lipids in large LDL percentage	APOB CELSR2 LPL	1.58e-04	31	100	3	EFO_0022249
Disease	LDL cholesterol change measurement	APOB CELSR2	2.36e-04	7	100	2	EFO_0007804
Disease	cholesteryl esters to total lipids in very large HDL percentage	APOB CELSR2 LPL	2.49e-04	36	100	3	EFO_0022257
Disease	free cholesterol to total lipids in large VLDL percentage	APOB CELSR2 LPL	2.70e-04	37	100	3	EFO_0022281
Disease	Malignant neoplasm of breast	FLNB ABCA3 BRIP1 BAG1 STAT5A EPG5 NF1 MTOR KCNH1 N4BP2 ANKRD30A ATM	2.81e-04	1074	100	12	C0006142
Disease	esterified cholesterol measurement, intermediate density lipoprotein measurement	APOB CELSR2	3.14e-04	8	100	2	EFO_0008589, EFO_0008595
Disease	familial hyperlipidemia (is_implicated_in)	APOB LPL	3.14e-04	8	100	2	DOID:1168 (is_implicated_in)
Disease	helping behavior measurement	BEND4 USH2A	3.14e-04	8	100	2	EFO_0008538
Disease	Hyperlipoproteinemia	GHR LPL	3.14e-04	8	100	2	cv:C0020476
Disease	Familial hypercholesterolemia	APOB GHR	3.14e-04	8	100	2	cv:C0020445
Disease	triglycerides to total lipids in large VLDL percentage	APOB CELSR2 LPL	3.16e-04	39	100	3	EFO_0022332
Disease	lipoprotein-associated phospholipase A(2) measurement	APOB CELSR2 LPL	3.41e-04	40	100	3	EFO_0004746
Disease	Inherited neuropathies	SPART KCNC3 ATM	3.41e-04	40	100	3	C0598589
Disease	triglycerides in large LDL measurement	APOB CELSR2 LPL	4.22e-04	43	100	3	EFO_0022319
Disease	cholesteryl esters to total lipids in small HDL percentage	APOB CELSR2 LPL	4.22e-04	43	100	3	EFO_0022254
Disease	free cholesterol to total lipids in very small VLDL percentage	APOB CELSR2 LPL	4.22e-04	43	100	3	EFO_0022290
Disease	total lipids in very small VLDL measurement	APOB CELSR2 LPL	4.83e-04	45	100	3	EFO_0022156
Disease	cholesterol to total lipids in large VLDL percentage	APOB CELSR2 LPL	4.83e-04	45	100	3	EFO_0022236
Disease	familial hypercholesterolemia (is_implicated_in)	APOB GHR	5.03e-04	10	100	2	DOID:13810 (is_implicated_in)
Disease	level of Triacylglycerol (51:3) in blood serum	APOB LPL	5.03e-04	10	100	2	OBA_2045163
Disease	free cholesterol in small VLDL measurement	APOB CELSR2 LPL	5.50e-04	47	100	3	EFO_0022272
Disease	free cholesterol in very small VLDL measurement	APOB CELSR2 LPL	5.50e-04	47	100	3	EFO_0022275
Disease	free cholesterol in medium VLDL measurement	APOB CELSR2 LPL	5.50e-04	47	100	3	EFO_0022269
Disease	apolipoprotein B to apolipoprotein A1 ratio	APOB CELSR2 LPL	6.21e-04	49	100	3	EFO_0021897
Disease	cholesteryl esters to total lipids in small VLDL percentage	APOB CELSR2 LPL	6.21e-04	49	100	3	EFO_0022256
Disease	triglycerides to total lipids in medium LDL percentage	APOB CELSR2 LPL	6.59e-04	50	100	3	EFO_0022334
Disease	free cholesterol in LDL measurement	APOB CELSR2 LPL	6.59e-04	50	100	3	EFO_0022266
Disease	Carcinoma, Granular Cell	STAT5A MTOR KRT20 CA1	6.65e-04	116	100	4	C0205644
Disease	Adenocarcinoma, Tubular	STAT5A MTOR KRT20 CA1	6.65e-04	116	100	4	C0205645
Disease	Adenocarcinoma, Oxyphilic	STAT5A MTOR KRT20 CA1	6.65e-04	116	100	4	C0205642
Disease	Carcinoma, Cribriform	STAT5A MTOR KRT20 CA1	6.65e-04	116	100	4	C0205643
Disease	Adenocarcinoma, Basal Cell	STAT5A MTOR KRT20 CA1	6.65e-04	116	100	4	C0205641
Disease	Adenocarcinoma	STAT5A MTOR KRT20 CA1	6.65e-04	116	100	4	C0001418
Disease	free cholesterol in large LDL measurement	APOB CELSR2 LPL	6.99e-04	51	100	3	EFO_0022176
Disease	total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement	APOB CELSR2 LPL	6.99e-04	51	100	3	EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928
Disease	triglycerides to total lipids in large LDL percentage	APOB CELSR2 LPL	6.99e-04	51	100	3	EFO_0022331
Disease	phospholipids in very small VLDL measurement	APOB CELSR2 LPL	6.99e-04	51	100	3	EFO_0022300
Disease	cholesterol to total lipids in small HDL percentage	APOB CELSR2 LPL	6.99e-04	51	100	3	EFO_0022240
Disease	integral membrane protein 2B measurement	APOB LPL	7.34e-04	12	100	2	EFO_0802634
Disease	phospholipids in medium VLDL measurement	APOB CELSR2 LPL	7.40e-04	52	100	3	EFO_0022154
Disease	triglycerides to total lipids in very large VLDL percentage	APOB CELSR2 LPL	7.82e-04	53	100	3	EFO_0022340
Disease	cholesterol in small VLDL measurement	APOB CELSR2 LPL	7.82e-04	53	100	3	EFO_0022228
Disease	free cholesterol in small LDL measurement	APOB CELSR2 LPL	7.82e-04	53	100	3	EFO_0022271
Disease	free cholesterol to total lipids in small LDL percentage	APOB CELSR2 LPL	7.82e-04	53	100	3	EFO_0022286
Disease	cholesteryl esters to total lipids in very large VLDL percentage	APOB CELSR2 LPL	7.82e-04	53	100	3	EFO_0022258
Disease	total lipids in medium VLDL	APOB CELSR2 LPL	8.26e-04	54	100	3	EFO_0022153
Disease	triglycerides in medium HDL measurement	APOB CELSR2 LPL	8.26e-04	54	100	3	EFO_0022321
Disease	cholesterol to total lipids in very large VLDL percentage	APOB CELSR2 LPL	8.26e-04	54	100	3	EFO_0022244
Disease	Hyperlipoproteinemia Type IIb	APOB LPL	8.66e-04	13	100	2	C1704417
Disease	triglycerides in medium VLDL measurement	APOB CELSR2 LPL	8.72e-04	55	100	3	EFO_0022155
Disease	leukemia	BRIP1 NF1 ATM	8.72e-04	55	100	3	C0023418
Disease	cholesterol to total lipids in large HDL percentage	APOB CELSR2 LPL	8.72e-04	55	100	3	EFO_0022234
Disease	phospholipids in medium HDL measurement	APOB CELSR2 LPL	8.72e-04	55	100	3	EFO_0022295
Disease	angina pectoris	ARHGEF12 APOB CELSR2 LPL	8.79e-04	125	100	4	EFO_0003913
Disease	triglycerides in LDL measurement	APOB CELSR2 LPL	9.19e-04	56	100	3	EFO_0022320
Disease	cholesterol to total lipids in large LDL percentage	APOB CELSR2 LPL	9.19e-04	56	100	3	EFO_0022235
Disease	free cholesterol to total lipids in large HDL percentage	APOB CELSR2 LPL	9.19e-04	56	100	3	EFO_0022279
Disease	cholesteryl esters to total lipids in large VLDL percentage	APOB CELSR2 LPL	9.19e-04	56	100	3	EFO_0022250
Disease	aspartate aminotransferase measurement	FLNB MCMBP BRIP1 SKIL STAU1 NF1 HMCN2 MTOR GCN1 ALPK2	9.98e-04	904	100	10	EFO_0004736
Disease	esterified cholesterol measurement, low density lipoprotein cholesterol measurement	APOB CELSR2	1.01e-03	14	100	2	EFO_0004611, EFO_0008589
Disease	vitamin D measurement	ASH1L APOB ZNF440 CELSR2 ZNF808 ZNF701	1.01e-03	336	100	6	EFO_0004631
Disease	triglycerides in IDL measurement	APOB CELSR2 LPL	1.02e-03	58	100	3	EFO_0022149
Disease	low density lipoprotein particle size measurement	APOB CELSR2 LPL	1.02e-03	58	100	3	EFO_0008593
Disease	cholesterol in IDL measurement	APOB CELSR2 LPL	1.02e-03	58	100	3	EFO_0021899
Disease	total lipids in medium HDL measurement	APOB CELSR2 LPL	1.02e-03	58	100	3	EFO_0022310
Disease	triglycerides to total lipids in small LDL percentage	APOB CELSR2 LPL	1.07e-03	59	100	3	EFO_0022337
Disease	cholesterol in medium HDL measurement	APOB CELSR2 LPL	1.07e-03	59	100	3	EFO_0021903
Disease	phospholipids in VLDL measurement	APOB CELSR2 LPL	1.07e-03	59	100	3	EFO_0022301
Disease	free cholesterol to total lipids in very large VLDL percentage	APOB CELSR2 LPL	1.07e-03	59	100	3	EFO_0022289
Disease	phospholipids in small VLDL measurement	APOB CELSR2 LPL	1.12e-03	60	100	3	EFO_0022146
Disease	total lipids in IDL	APOB CELSR2 LPL	1.12e-03	60	100	3	EFO_0022161
Disease	total lipids in VLDL measurement	APOB CELSR2 LPL	1.12e-03	60	100	3	EFO_0022314
Disease	free cholesterol to total lipids in medium HDL percentage	APOB CELSR2 LPL	1.12e-03	60	100	3	EFO_0022282
Disease	body weight	ATXN2L MDFIC TRAF3 HIVEP1 HDX ARHGEF12 CEP192 RFX3 GHR HHLA2 MTOR ITIH6	1.15e-03	1261	100	12	EFO_0004338
Disease	low density lipoprotein triglyceride measurement	APOB LPL	1.16e-03	15	100	2	EFO_0009946
Disease	Neoplasm of uncertain or unknown behavior of bladder	MTOR ATM	1.16e-03	15	100	2	C0496930
Disease	Benign neoplasm of bladder	MTOR ATM	1.16e-03	15	100	2	C0154017
Disease	triacylglycerol 52:3 measurement	APOB LPL	1.16e-03	15	100	2	EFO_0010415
Disease	Carcinoma in situ of bladder	MTOR ATM	1.16e-03	15	100	2	C0154091
Disease	response to statin, LDL cholesterol change measurement	APOB CELSR2	1.16e-03	15	100	2	EFO_0007804, GO_0036273
Disease	free cholesterol in IDL measurement	APOB CELSR2 LPL	1.18e-03	61	100	3	EFO_0022181
Disease	free cholesterol in VLDL measurement	APOB CELSR2 LPL	1.18e-03	61	100	3	EFO_0022276
Disease	phospholipids in HDL measurement	APOB CELSR2 LPL	1.18e-03	61	100	3	EFO_0022293
Disease	triglycerides in medium LDL measurement	APOB CELSR2 LPL	1.24e-03	62	100	3	EFO_0022322
Disease	free cholesterol in very large HDL measurement	APOB CELSR2 LPL	1.24e-03	62	100	3	EFO_0022273
Disease	coronary artery disease, plasminogen activator inhibitor 1 measurement	APOB CELSR2 LPL	1.29e-03	63	100	3	EFO_0001645, EFO_0004792
Disease	triglycerides to total lipids in IDL percentage	APOB CELSR2 LPL	1.29e-03	63	100	3	EFO_0022329
Disease	Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	MTOR ATM	1.32e-03	16	100	2	C0334634
Disease	triglycerides in small LDL measurement	APOB CELSR2 LPL	1.42e-03	65	100	3	EFO_0022323
Disease	cholesterol in large VLDL measurement	APOB CELSR2 LPL	1.42e-03	65	100	3	EFO_0021902
Disease	cholesterol in very large VLDL measurement	APOB CELSR2 LPL	1.42e-03	65	100	3	EFO_0022230
Disease	total lipids in very large HDL measurement	APOB CELSR2 LPL	1.48e-03	66	100	3	EFO_0022312
Disease	Lipidemias	APOB LPL	1.50e-03	17	100	2	C1706412
Disease	cholesterol to total lipids in chylomicrons and extremely large VLDL percentage	APOB CELSR2	1.50e-03	17	100	2	EFO_0022232
Disease	Hyperlipidemia	APOB LPL	1.50e-03	17	100	2	C0020473
Disease	total lipids in small VLDL	APOB CELSR2 LPL	1.55e-03	67	100	3	EFO_0022148
Disease	total lipids in large VLDL	APOB CELSR2 LPL	1.55e-03	67	100	3	EFO_0022175

Protein segments in the cluster

Peptide	Gene	Start	Entry
QQVTHKVAQHLTGAS	EPG5	1101	Q9HCE0
SHTLFAESGNKVQHI	AGK	161	Q53H12
KFGNADVVNVLSSHH	ANKLE2	421	Q86XL3
KNQFTSESTHLNVGH	ASH1L	601	Q9NR48
SHKATVHVRVNDVNE	CLSTN3	126	Q9BQT9
SGENSTVAEHLIAQH	COPS6	211	Q7L5N1
GVHKENASLAQHSEV	ALPK2	696	Q86TB3
HIGKGVHSQTSDNVD	BEND4	216	Q6ZU67
KRVEDSSSNGQAHIH	ARID2	581	Q68CP9
KSVESNLNQVSHTHE	ANKRD30A	1081	Q9BXX3
QAKHVQFVSGVHVAS	ABCA3	1126	Q99758
AAGLTVTVTHSNEKH	BAG1	141	Q99933
SNEKHDLHVTSQQGS	BAG1	151	Q99933
TKSTHVFRVTAQDHG	CELSR2	251	Q9HCU4
VVQLSHKANFGASHS	ASXL1	1471	Q8IXJ9
FHASNTHLQKTGTAE	ATP5F1A	36	P25705
AHVTQAHVQTGITAA	ATXN2L	961	Q8WWM7
KVNGTLVTHSNHLEV	ARHGEF12	116	Q9NZN5
NASNVKHHDSSALGV	PTPN22	511	Q9Y2R2
TNTQTGEEHTVTHLQ	PTPN3	791	P26045
QQLTGVATHTSVQHA	HIPK2	721	Q9H2X6
GTNKHTDTQITEAHK	HDX	121	Q7Z353
HIETHQNTSKNVAAV	NEMF	851	O60524
KDITQATNSHFTHGE	MDFIC	41	Q9P1T7
NNTAVVAVETHTIHK	GMEB1	61	Q9Y692
GEHAENAVQIHKVVT	LRRTM1	416	Q86UE6
IHTSSQHFSQGVEVK	HMCN2	611	Q8NDA2
SAGVAHKHVFLTVQA	HMCN2	3926	Q8NDA2
GKVEGHQHIQVSTSS	LBHD1	41	Q9BQE6
TQAGIVAHIQEVTHN	CCDC88C	151	Q9P219
DTKAAVAAHIQEVTH	CCDC88A	151	Q3V6T2
ENGVHTIDVKFNGSH	FLNB	2351	O75369
KIHFSGTESETHTNQ	LPL	346	P06858
ETQDHKSAVRGNNTH	GAPT	76	Q8N292
TVHVEPSQETASHNK	HHLA2	331	Q9UM44
VEKGNVLTEHASANH	KCNH1	766	O95259
SDKGQAQHSHLTEAT	LRRC37B	401	Q96QE4
AKTFEQLHSTIGHQA	GCN1	2026	Q92616
HQSQQSTVDVGQLHD	PRDM10	956	Q9NQV6
AQVQAAAAATVKAHH	NLK	111	Q9UBE8
HDKVHTVVASNNGSV	PCCA	566	P05165
HKHLGNTVNVEVDAA	KRT20	216	P35900
HTQIQAGSHTETVEQ	CRNN	346	Q9UBG3
FQSDKVTIVDHHSAT	NOS1	646	P29475
VHKISDQHTLQTFQG	BRIP1	316	Q9BX63
QETHRESTTEQGQHK	EFCAB5	566	A4FU69
HSSAQIVSKHLVGVD	EIF2B3	341	Q9NR50
IEKHQSSIGFSVHQN	ATM	671	Q13315
QVDSQHVGHSVLTAK	APOB	2991	P04114
QKSGSSTHQLEVHIE	BMP10	211	O95393
TEGAESTHQAAHIQL	GHR	461	P10912
VGQSKDENIHTSHIT	CENPC	436	Q03188
TAKEIINVGHSFHVN	CA1	56	P00915
GASSLHIQAVTQEHA	CDON	481	Q4KMG0
DESHKESSQHVTQLV	HAS2	161	Q92819
EVQFIITGTNHHSEK	PRMT5	261	O14744
NVETVEASVHSSNAH	ELF2	76	Q15723
VAHHSEGATNNSQKA	ITIH6	531	Q6UXX5
SEISNSEKHVTFENH	CEP192	941	Q8TEP8
HQDHAVNAKVQAESA	LAMB4	1641	A4D0S4
TKNNIAVSSDHHVIS	CEP295	916	Q9C0D2
AVSSDHHVISQLQDK	CEP295	921	Q9C0D2
ETEKFGQGVHHAASQ	SBSN	346	Q6UWP8
ILEGKHHQASETHNV	SLC39A9	66	Q9NUM3
DSQVNQKSTVVIHHF	PKD1L1	461	Q8TDX9
ETVNQNTKAHVLHFG	MCMBP	86	Q9BTE3
TDSKHNKVGVTFNAH	PPEF1	321	O14829
LISGHAHVVSQTAVQ	MTOR	636	P42345
VSHNIAKVEQHVVDG	RTCB	351	Q9Y3I0
ETKIIHINTTHNSFG	USH2A	4576	O75445
VIKQEGDHVSQTHSF	SKIL	381	P12757
VAAVAVGHQHNHQTV	SLC25A34	136	Q6PIV7
GTSVEQTVIAQSQHH	RFX3	306	P48380
VVVIVHGSQDHNATA	STAT5A	466	P42229
AHQIHQGLQASSAKE	CHST15	321	Q7LFX5
GKAFSVHSNLATHQV	ZNF665	576	Q9H7R5
SSHVDENDVQTVSHK	TNRC18	2906	O15417
VIVSGHQKSTTVSHE	SLC25A14	21	O95258
SVNSFQRHEKIHSGE	ZNF440	351	Q8IYI8
ATHHAVDSAVNVGVT	SPART	586	Q8N0X7
QQIKAHEASSAVQHV	TRAF3	246	Q13114
QNSEHHGQSIKTQTD	ZNF490	41	Q9ULM2
GHQSAVSAVAAVEEH	TEP1	2146	Q99973
QAVGVSQGHHTKDFT	STAU1	426	O95793
AKTVQGSGHQEHINI	CTTN	41	Q14247
QNSSLVDHQKIHTGA	ZIK1	306	Q3SY52
HVVTQNGAEASSVKT	ZNF609	826	O15014
FHHEASGVTVKNLQA	WDFY4	371	Q6ZS81
NISKENEVQSSHHGE	XRN1	1326	Q8IZH2
QNSALVIHKAIHTGE	ZNF808	326	Q8N4W9
GQQNTHTKVSTEHNK	NF1	26	P21359
NVSKETHASVIAHVT	PREX2	726	Q70Z35
TKSEDQSHVVQEHLS	ZNF518A	356	Q6AHZ1
SSNLVQHQSIHSGVK	ZNF780A	261	O75290
GKAFSEHSNLTTHQV	ZNF347	631	Q96SE7
QSSAHIVHQKTQAGD	ZNF658	336	Q5TYW1
ISHVEKAHITAESAQ	ZNF536	316	O15090
FSQGAHLQTHQKVHV	ZNF226	316	Q9NYT6
SRHQQTHIGEKSDVA	ZNF717	886	Q9BY31
TSSEHHVNAVFQKTI	TOPAZ1	406	Q8N9V7
SIHSVNVFQGHTDTV	WDR37	356	Q9Y2I8
NTEVVHTGTLQIHAS	ZNF701	131	Q9NV72
DNSTVLEHQKIHTGE	ZNF485	281	Q8NCK3
AHFQVHSAGAVTVLK	TBC1D2B	106	Q9UPU7
QQLVSHEVTQHEAGS	UNC13D	306	Q70J99
LEGKQDSHVGTVHAQ	HIVEP1	631	P15822
SQSSAHIVHQKTQAG	ZNF658B	91	Q4V348
THEGFIHISNKTVTQ	KCNC3	311	Q14003
FVHQNENVTSHTGQK	N4BP2	1576	Q86UW6